Latest in a series of breakthrough discoveries by the Fred Hutchinson Cancer Research Center’s Stephen Tapscott and an international team of researchers may lead to biomarker tests, new treatments
Tapscott’s global team discovers expression of an MD-causing gene thought to be inactive in humans; work may lead to new therapy targets, evolutionary insights